register

News & Trends - MedTech & Diagnostics

Baxter to expand local manufacturing with NSW Government investment

Health Industry Hub | May 12, 2021 |

MedTech News: Baxter Healthcare, a local manufacturer of Australian made medical products, announced a major expansion of its Western Sydney advanced manufacturing facility.

Premier Gladys Berejiklian said the $250 million program from Investment NSW was an opportunity for the state to invest in its future prosperity by nurturing industries, technology and stimulating job creation.

As Australia’s only local manufacturing facility for IV medical fluids, Baxter will expand its manufacturing operations in Old Toongabbie, NSW, to strengthen Australia’s national medical supply chain and exports of Australian Made medicines to the Oceania Region.

With the funding support from NSW Government’s Job Plus program, Baxter will install a new additional production filling line for its intravenous (IV) medical fluids.

The expanded facility is expected to create approximately 80 new advanced manufacturing jobs, in addition to jobs created due to construction.

General Manager for Baxter Australia & New Zealand, Steven Flynn said “Baxter is proud to partner with the NSW Government to invest in our modern manufacturing operations in Western Sydney and create jobs in the local medtech sector.

“This major expansion of Baxter’s medical manufacturing facility will help to strengthen our national supply chain resilience and support continued export growth of Australian Made medicines.

“Baxter intravenous (IV) medicines are the backbone of medication delivery in the ICU, oncology wards, emergency rooms and operating theatres across Australia and the South Pacific.”

“As Australia’s only local manufacturer of IV medical fluids, Baxter is committed to supporting our hospitals and healthcare professionals with reliable supply of medicines during the pandemic and beyond,” Mr Flynn added.

Minister for Jobs, Investment, Tourism and Western Sydney Stuart Ayres said supporting the growth of medical technology and healthcare innovation protected lives as well as the economy.

“The pandemic put a spotlight on the value of these high-growth, essential industries and backing their growth is crucial to ensure our economy is fuelled by sustainable, knowledge-based jobs that are here for the long run,” Mr Ayres stated.


News & Trends - Biotechnology

Aussie biotech secures agreement with UQ and USyd to advance cardiovascular diseases research

Aussie biotech secures agreement with UQ and USyd to advance cardiovascular diseases research

Health Industry Hub | July 26, 2024 |

Biotech News: Australian biotechnology company, Cartherics, developing immune cell therapies for the treatment of cancer, has entered into a Technology […]

More


News & Trends - MedTech & Diagnostics

NSW Health Secretary urges more focus on patient experience, drawing from her own heart valve disease journey

NSW Health Secretary urges more focus on patient experience, drawing from her own heart valve disease journey

Health Industry Hub | July 26, 2024 |

In a heart-warming event that united patients, their loved ones, representatives from patient organisations and employees, Edwards Lifesciences hosted its […]

More


Human Resources

'To be an inclusive society, we need an embedded national strategy to combat systemic racism', says Commissioner Sivaraman

‘To be an inclusive society, we need an embedded national strategy to combat systemic racism’, says Commissioner Sivaraman

Health Industry Hub | July 26, 2024 |

Race Discrimination Commissioner Giridharan Sivaraman has welcomed the release of the Multicultural Framework Review by the Federal Government, calling it […]

More


News & Trends - Pharmaceuticals

New shingles vaccine is linked with lower risk of dementia

Shingles vaccine lowers risk of dementia

Health Industry Hub | July 26, 2024 |

Pharma News: A recombinant shingles vaccine which was added to Australia’s National Immunisation Program (NIP) in November last year, is […]

More


This content is copyright protected. Please subscribe to gain access.